These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11586893)

  • 1. Accelerating RNA decay through intervention of RNase L: alternative synthesis of composite 2',5'-oligoadenylate-antisense.
    Torrence PF; Wang Z
    Methods Enzymol; 2001; 342():20-8. PubMed ID: 11586893
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
    Cramer H; Player MR; Torrence PF
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
    Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
    Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
    [No Abstract]   [Full Text] [Related]  

  • 5. RNase L: effector nuclease of an activatable RNA degradation system in mammals.
    Bisbal C
    Prog Mol Subcell Biol; 1997; 18():19-34. PubMed ID: 8994259
    [No Abstract]   [Full Text] [Related]  

  • 6. RNase L, a (2'-5')-oligoadenylate-dependent endoribonuclease: assays and purification of the enzyme; cross-linking to a (2'-5')-oligoadenylate derivative.
    Floyd-Smith G; Lengyel P
    Methods Enzymol; 1986; 119():489-99. PubMed ID: 2429152
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
    Silverman RH; Dong B; Maitra RK; Player MR; Torrence PF
    Methods Enzymol; 2000; 313():522-33. PubMed ID: 10595377
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling gene expression with 2-5A antisense.
    Leaman DW; Cramer H
    Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
    Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
    Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
    Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids.
    Wang Z; Chen L; Bayly SF; Torrence PF
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1357-60. PubMed ID: 10890163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activation.
    Shetzline SE; Suhadolnik RJ
    J Biol Chem; 2001 Jun; 276(26):23707-11. PubMed ID: 11323422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
    Chapekar MS; Glazer RI
    Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
    [No Abstract]   [Full Text] [Related]  

  • 16. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
    Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
    Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.
    Verheijen JC; van der Marel GA; van Boom JH; Bayly SF; Player MR; Torrence PF
    Bioorg Med Chem; 1999 Mar; 7(3):449-55. PubMed ID: 10220031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
    Ueno Y; Kato Y; Okatani S; Kitade Y
    Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
    Salehzada T; Silhol M; Steff AM; Lebleu B; Bisbal C
    J Biol Chem; 1993 Apr; 268(11):7733-40. PubMed ID: 8463302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.